82 related articles for article (PubMed ID: 2932218)
1. Splenic immune effector and suppressor cells in mice bearing a growing plasmacytoma.
Chen YH; Anderson AB; Williams KG
Cancer Res; 1985 Nov; 45(11 Pt 1):5473-9. PubMed ID: 2932218
[TBL] [Abstract][Full Text] [Related]
2. Effector mechanism of tumor immunity in murine plasmacytoma.
Chen YH; Anderson AB
Cancer Res; 1988 Mar; 48(6):1398-403. PubMed ID: 3257896
[TBL] [Abstract][Full Text] [Related]
3. Regulation of immune responses aginst the syngeneic ADJ-PC-5 plasmacytoma in BALB-c mice. III. Induction of specific T suppressor cells to the BALB/c plasmacytoma ADJ-PC-5 during early stages of tumorigenesis.
Haubeck HD; Kölsch E
Immunology; 1982 Nov; 47(3):503-10. PubMed ID: 6215340
[TBL] [Abstract][Full Text] [Related]
4. Cyclophosphamide-induced appearance of immunopotentiating T-cells in the spleens of mice bearing a large MOPC-315 tumor.
Ye QW; Mokyr MB
Cancer Res; 1984 Sep; 44(9):3873-9. PubMed ID: 6611201
[TBL] [Abstract][Full Text] [Related]
5. Hybrid resistance to BALB/c plasmacytomas: F1 hybrid anti-MPC-11 immunological responses correlated with resistance to tumor challenge.
Marsili MA; Walker MC; Phillips-Quagliata JM
Cancer Res; 1986 Jan; 46(1):190-7. PubMed ID: 3484380
[TBL] [Abstract][Full Text] [Related]
6. Isolation and characterization of in vitro and in vivo functions of a tumor-specific T suppressor cell clone from a BALB/c mouse bearing the syngeneic ADJ-PC-5 plasmacytoma.
Haubeck HD; Kölsch E
J Immunol; 1985 Dec; 135(6):4297-302. PubMed ID: 2415609
[TBL] [Abstract][Full Text] [Related]
7. Cellular changes and antitumor responses in the plasmacytoma-bearing mouse following cyclophosphamide treatment.
Shanahan TC; Ceglowski WS; Havas HF
Cancer Res; 1985 Dec; 45(12 Pt 1):6463-70. PubMed ID: 2866030
[TBL] [Abstract][Full Text] [Related]
8. Some characteristics of the cyclophosphamide-induced immunopotentiating cells in the spleen of mice bearing a large MOPC-315 tumor.
Mokyr MB; Ye QW
Cancer Res; 1985 Oct; 45(10):4932-9. PubMed ID: 4027979
[TBL] [Abstract][Full Text] [Related]
9. Immunosuppression in plasmacytoma: induction of suppressor cells.
Chen Y; Hwang LT; Heller P
Clin Exp Immunol; 1982 Jan; 47(1):191-6. PubMed ID: 6212173
[TBL] [Abstract][Full Text] [Related]
10. Importance of cyclophosphamide-induced bystander effect on T cells for a successful tumor eradication in response to adoptive immunotherapy in mice.
Proietti E; Greco G; Garrone B; Baccarini S; Mauri C; Venditti M; Carlei D; Belardelli F
J Clin Invest; 1998 Jan; 101(2):429-41. PubMed ID: 9435316
[TBL] [Abstract][Full Text] [Related]
11. Tumor-specific suppressor T-cells which inhibit the in vitro generation of cytolytic T-cells from immune and early tumor-bearing host spleens.
Bear HD
Cancer Res; 1986 Apr; 46(4 Pt 1):1805-12. PubMed ID: 2936451
[TBL] [Abstract][Full Text] [Related]
12. Role of antitumor immunity in cyclophosphamide-induced rejection of subcutaneous nonpalpable MOPC-315 tumors.
Mokyr MB; Hengst JC; Dray S
Cancer Res; 1982 Mar; 42(3):974-9. PubMed ID: 6977410
[TBL] [Abstract][Full Text] [Related]
13. Modulation of cellular anti-tumour responses by tumour-specific T suppressor lymphocytes.
Haubeck HD; Stutenkemper R; Kölsch E
Clin Exp Immunol; 1988 Oct; 74(1):47-52. PubMed ID: 2975538
[TBL] [Abstract][Full Text] [Related]
14. Induction by cyclophosphamide administration of two distinct anti-tumor effector cells at tumor site and spleen of mice transplanted with MOPC-104E plasmacytoma.
Nio Y; Ohgaki K; Tobe T
J Clin Lab Immunol; 1989 May; 29(1):37-43. PubMed ID: 2534133
[TBL] [Abstract][Full Text] [Related]
15. Gamma delta T cells in normal spleen assist immunized alpha beta T cells in the adoptive cell transfer of contact sensitivity. Effect of Bordetella pertussis, cyclophosphamide, and antibodies to determinants on suppressor cells.
Askenase PW; Szczepanik M; Ptak M; Paliwal V; Ptak W
J Immunol; 1995 Apr; 154(8):3644-53. PubMed ID: 7706708
[TBL] [Abstract][Full Text] [Related]
16. Selective in-vitro activation of BALB/c T suppressor lymphocytes specific for syngeneic ADJ-PC-5 plasmacytoma cells.
Haubeck HD; Minkenberg I; Kölsch E
Clin Exp Immunol; 1988 Oct; 74(1):53-8. PubMed ID: 2975539
[TBL] [Abstract][Full Text] [Related]
17. Generation from tumor-bearing mice of lymphocytes with in vivo therapeutic efficacy.
Shu SY; Chou T; Rosenberg SA
J Immunol; 1987 Jul; 139(1):295-304. PubMed ID: 2953816
[TBL] [Abstract][Full Text] [Related]
18. Natural suppressor (NS) cells found in the spleen of neonatal mice and adult mice given total lymphoid irradiation (TLI) express the null surface phenotype.
Oseroff A; Okada S; Strober S
J Immunol; 1984 Jan; 132(1):101-10. PubMed ID: 6228575
[TBL] [Abstract][Full Text] [Related]
19. Some advantages of curing mice bearing a large subcutaneous MOPC-315 tumor with a low dose rather than a high dose of cyclophosphamide.
Mokyr MB; Dray S
Cancer Res; 1983 Jul; 43(7):3112-9. PubMed ID: 6850619
[TBL] [Abstract][Full Text] [Related]
20. Non-specific regulatory mechanism of contact sensitivity: the requirement of intermediate cells for non-specific suppressor factor (NSF) activity.
Nakano Y
Immunology; 1988 Jun; 64(2):261-6. PubMed ID: 2968951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]